{"id":"W2520458330","doi":"10.1016/s0923-7534(20)34031-x","title":"Clinical Benefit with Regorafenib Across Subgroups and Post-Progression in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) After Progression on Imatinib (IM) and Sunitinib (SU): Phase 3 Grid Trial Update","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Regorafenib; Medicine; GiST; Sunitinib; Imatinib; Internal medicine; Oncology; Stromal tumor; Stromal cell; Colorectal cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002097421,0.001074509,0.003080876,0.0003713446,0.0003144587,0.0009969752,0.000570038,0.0008197794,0.002736924],"category_scores_gemma":[0.001667623,0.0002680933,0.002810125,0.000675857,0.0004971651,0.001200084,0.0004089935,0.002107872,0.0005245431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007597053,"about_ca_system_score_gemma":0.0008788439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001057161,"about_ca_topic_score_gemma":0.005448133,"domain_scores_codex":[0.9994643,0.0002722718,0.00004832641,0.00008728795,0.00004887574,0.00007884989],"domain_scores_gemma":[0.9991261,0.0002842705,0.0002209037,0.0000827152,0.00005702422,0.0002288704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5870451,0.004048494,0.05137467,0.002221256,0.009108221,0.0001992944,0.0002960024,0.005459133,0.01165145,0.0005089272,0.01606054,0.312027],"study_design_scores_gemma":[0.5658023,0.1791477,0.2058783,0.000444414,0.01049045,0.001040073,0.0004067052,0.003286281,0.003821996,0.003362195,0.02615563,0.0001639561],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.961413,0.02145826,0.0009809516,0.002474493,0.0003509826,0.0008920399,0.006660598,0.0002284986,0.005541206],"genre_scores_gemma":[0.9772931,0.008027129,0.001996953,0.002084759,0.0003231432,0.001081364,0.007376012,0.0000682927,0.001749204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003080876,"threshold_uncertainty_score":0.01109236,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0502119255854298,"score_gpt":0.4397055670542832,"score_spread":0.3894936414688533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}